Twenty per cent of cervical intraepithelial neoplasias-III (CIN-III) progress to invasive cancer. Human papillomavirus (HPV) infection alone does not determine progression. CIN-III lesions were collected from 161 women. Each tissue was microdissected into a maximum of 32 contiguous units and assayed at multiple microsatellite loci on chromosome 11q, a region frequently deleted in invasive cervical and other cancers. Eight of 108 informative cases (7%) had 11q23.3-q25 deletions; focally intra-lesional in six (one with focal loss of alternate alleles), and pan-lesional in two cases. Hence, 11q deletion can occur early in cervical neoplasia, and possibly predisposes to invasion.
Introduction
Invasive cervical cancer is regarded as evolving from a pre-invasive lesion viz. cervical intraepithelial neoplasia (CIN) grades I, II and III. Over the past decade the role of human papillomavirus (HPV) infection in this process has been examined intensively. Infection with certain`high-risk' types, especially HPV 16 or 18 ful®ls the epidemiological criteria necessary to de®ne the virus as the cause of most cases of CIN (Schiman et al., 1993) . HPV infection however is not sucient for disease progression. The regression/persistence/progression rates for CIN-I lesions have been estimated as 62, 22 and 16% respectively, and for CIN-II lesions as 54, 16 and 30% (Nasiell et al., 1983 (Nasiell et al., , 1986 . In a study of over 1000 women presenting with severely dyskaryotic (CIN-III) smears, there was regression in 44% of cases, persistence in 36% and progression to invasive carcinoma in 20% (Yajima et al., 1979) . Factors favouring progression through to invasive disease include epigenetic in¯uences such as smoking and parity (Schiman et al., 1993) and immune system failure to clear HPV infection (Rocha-Zavaleta et al., 1997) . The importance of aberrations in the native genome also requires clari®cation.
Somatic gene mutations arising during the development of cervical neoplasia have yet to be molecularly characterized in detail although disruption of the genetic character of cells isolated from CIN lesions or cervical cancers has long been recognized by cytogenetic analyses (Spriggs, 1974) . Non-random chromosomal changes involving chromosomes 1, 3, 6, 11 and 22 have been observed in cancers. Chromosomes 1 and 11 aberrations are the most common (Sreekantaiah et al., 1991) . Chromosome 11 has proved of particular interest because of a functional anti-tumorigenic property. Introduction of a normal human chromosome 11 into cervical cell lines such as HeLa (HPV 18 positive) (Saxon et al., 1986) and SiHa (HPV 16 positive) (Koi et al., 1989; Oshimura et al., 1990) rendered each line non-tumorigenic in vivo. Subsequent loss of the introduced chromosome led to reappearance of the malignant phenotype. Chromosome 11`tumour suppression' has also been reported for HPV negative cell lines (Oshimura et al., 1990) .
Allelic imbalance of chromosome 11 in cervical carcinomas has been analysed using RFLP and/or microsatellite PCR techniques. The frequency of loss of heterozygosity (LOH) or allelic deletion for an entire or sub-region of chromosome 11 occurs in 22 ± 44% of invasive cervical cancers (Hampton et al., 1994; Bethwaite et al., 1995; Mullokandov et al., 1996; Huettner et al., 1996) . The minimum region of loss in each study spanned the 11q23 locus. Loss of the 11q23 region has also been reported as a frequent occurrence in other cancers e.g. in up to 59% of breast tumours (Tomlinson et al., 1995) . In breast cancers 11q23 LOH is associated with aggressive tumours and poor prognosis (Gudmundsson et al., 1995) , and in a study of 40 ovarian cancers each had some 11q loss but poor survival only correlated with 11q23.3-11q24.3 LOH (Gabra et al., 1996) . This study aimed to de®ne the role of 11q23 deletions in pre-invasive cervical neoplasia (CIN-III) by whole lesion assays using microdissection and PCR for multiple microsatellite markers on 11q on a large sample set.
Results
This study was conducted in two phases. Initially CIN-III lesions from 161 women were analysed for LOH at the D11S29 locus at 11q23.3. This marker was chosen because of its high frequency of LOH in carcinoma studies (Bethwaite et al., 1995; Tomlinson et al., 1995) . At the outset of the study there was speculation over the clonal status of the CIN condition (Burghardt and O È stoÈ r, 1983; Burghardt, 1992) . Consequently dysplastic epithelia were sampled by microdissection at up to 12 discontinuous points within a lesion (Figure 2b ). Normal epithelia and/or endocervical lining cells were taken as control tissues. Tissues were generally analysed from at least two tissue blocks when available. Cases with LOH by visual inspection of autoradiograph relative band intensities were further analysed at the CD3D locus which lies approximately 1 cM (1 Mb) distal to D11S29. From this analysis at least eight out of 108 informative cases (7%) were assessed as possibly LOH-positive. The patterns of LOH indicated that in some cases loss was restricted to a de®ned intra-lesional focus and was pan-lesional in others. In one case loss of alternate alleles was implicated.
In the second phase, to further con®rm these ®ndings tissue sections were again cut from these eight cases and also from eight LOH-negative cases as a control measure. Multiple samples of normal tissue (usually eight), were taken and the entire neoplastic lesion was microdissected into up to 24 contiguous samples depending on lesion size. Microsatellite PCR at D11S29 and CD3D was repeated, and in addition microsatellite loci at D11S554 (11p12), D11S534 (11q13), D11S901 (11q14), D11S35 (11q22), D11S897 (11q23.3) and D11S969 (11q24-25) were also assayed to map the extent of deletion. All PCRs were performed at least twice per microdissected tissue sample to con®rm reproducibility and assessed by densitometry.
The results are summarized in Figure 1 . Eight of 108 (7%) informative cases were accepted as LOH positive. None of the control cases gave abnormal band patterns. In two cases the entire CIN lesion examined contained LOH (e.g. Figures 2a and 3 ). In the other six cases LOH was con®ned to a particular intra-lesional location or to the samples taken from just one tissue block (e.g. Figures 2c and 4 ). The pattern of alternate allele loss was again found for one case ( Figure 5 ). There were no morphological features distinguishing the LOH tissues from adjacent CIN. The minimum region of loss extended from D11S29 (11q23.3) to D11S969 (11q24-25).
The HPV status of the 8 LOH cases was examined by PCR for E6/E7 sequences followed by restriction enzyme digestion. All cases were HPV positive by PCR, seven for HPV16 and one for HPV 33 (data not shown).
The ages of the women in this study ranged from 18.6 to 61.4 years at the time of treatment. The age range for the LOH women was 18.6 to 44.5 years. There was no signi®cant age-related dierence between loss positive and loss negative groups. The youngest woman in this study showed the loss of alternate alleles and had one of the most extensive lesions.
Discussion
At a 7% incidence of LOH in CIN-III, if all cases with 11q LOH are assumed to progress to invasion, the expected frequency of LOH at 11q in invasive cervical cancer would be *35% (assuming 20% general progression rate for CIN-III (Yajima et al., 1979; McIndoe et al., 1984) . This ®gure is concordant with the 22 ± 44% 11q LOH actually detected (Hampton et al., 1994; Bethwaite et al., 1995; Mullokandov et al., 1996; Huettner et al., 1996) and consistent with 11q23 LOH representing an important early indicator (and possible determinant) of invasive cancer. During the completion of this study Larson et al. (1997) also reported LOH on 11q in CIN lesions. In their investigation into the origin of multifocal CINs of all grades from 16 women, 41 CIN foci were collected and analysed for LOH at loci along 3p, 4p, 4q, and 11q (including D11S29). LOH was recorded at some locus on 11q in 9 of 17 (53%) CIN-III foci examined and where one CIN focus demonstrated a particular LOH so did other foci from the same woman. However it is not possible to compare the two studies directly because multifocal lesions (which may be biologically Figure 1 Results summary: chromosome 11 ideogram and case microsatellite LOH pro®les 11q23.3 ± q25 LOH in CIN III MF Evans et al distinct) were purposefully targeted to investigate a dierent question and it is not detailed what number of women (rather than foci) had some 11q LOH and speci®cally 11q23.3 loss. In`Phase I' of our study we deliberately searched for CIN-IIIs with LOH at this locus. Those lesions most likely to progress or to contain unidenti®ed micro-invasions have extensive involvement of surface epithelium and features such as deep endocervical gland involvement (Al Nafussi and Hughes, 1994) . Our study comprised a heterogeneous collection of CIN-III lesions ranging in size from highly focal and 51 mm in length to nearly 4 cm, and varying in involvement of endocervical glands. The LOH cases ranged in size from 0.5 ± 3.5 cm and signi®cant gland involvement was evident in only two cases. No evidence of microinvasion was found upon extensive sectioning through the cases, consistent with 11q23 LOH being an early event in cervical neoplasia, occurring prior to invasion.
An investigation of low-and high-grade cervical lesions for HPV status and clonality relative to an Xlinked marker found that all 25 high-grade lesions and the majority of low-grades infected with a high or intermediate risk HPV type (e.g. HPV 16 or 33) were monoclonal (Park et al., 1996) . Assuming this premise our data is consistent with sub-clonal genetic divergence occurring in monoclonal CIN-III lesions in the absence of phenotypic variation. However LOH analyses on other chromosomes in multiple sections of the lesions examined is necessary to con®rm or refute this suggestion.
The ®nding of loss of alternate alleles in one case does not easily ®t with the model involving loss of the Figure 3 . CIN-III tissues from two biopsy sections of case 41 (2c) were sampled. Sequential microsatellite PCR results from these two sections (Ta and Tb) are shown in Figure 4 11q23.3 ± q25 LOH in CIN III MF Evans et al wild type gene and persistence of a defective one. However, this observation is accounted for by a gene dosage model in which just`one hit' is required for a signi®cant deleterious biological eect. Such a theory has been proposed following observations of a HeLa cell sub-line and variations in its tumorigenicity relative to changes in chromosome 11 RFLP patterns (Horikawa et al., 1995) .
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HPVs are not the simple cause of cervical carcinoma despite the strong association between their presence and disease. HPV infections are frequently transient and asymptotic (Hinchlie et al., 1995) and of little value as`snap-shot' predictors of disease progression (Downey et al., 1994) . While persistent high-grade HPV infection remains the most important risk factor for chronic severe dysplasia (and presumably progression to invasion) (Ho et al., 1995; Remmink et al., 1995; Romanini et al., 1995) , no direct relationshiop between HPV positivity and the development of lymph node metastases/5-year survival of women suering low-stage invasive cervical cancer has been found (Kenter et al., 1993; van-Bommel et al., 1993) . Further, cell lines established following the transformation of normal cervical epithelial cells with HPV 16 DNA contained integrated HPV sequences, expressed E6 and E7 mRNA and displayed aneuploidy yet were non-tumorigenic (Waggoner et al., 1990; Pecoraro et al., 1991; Tsutsmi et al., 1992) . Only after some time (and additional unde®ned mutations) did a limited number of tumorigenic sub-lines emerge (Pecoraro et al., 1991) .
The E6/E7 genes of the high-risk HPV types are recognized as having oncogenic potential. E6 abrogates p53 function and E7 retinoblastoma (Munger et al., 1992) . E6/E7 activity also disrupts cyclin-cdk complexes (Xiong et al., 1996) . In cell line experiments, disruption of the latter was found to be associated with ploidy/aneuploidy, translocation events, and loss of cell cycle check-point control even in pre-neoplastic mortal cells. Thus HPV E6/E7 expression is directly linked to loss of genomic stability which manifests as varieties of chromosomal abnormalities (Sreekantaiah et al., 1991) and as commonplace LOH (Huettner et al., 1996) .
Cancer-susceptibility genes have been classed as gatekeepers ' or`caretakers' (Kinzler and Vogelstein, 1997) . The latter maintain the integrity of the genome and only initiate tumorigenesis indirectly. A persistent Figure 3 Pan-lesional LOH. Case 15 was microdissected into 18 contiguous units of lesion, six of which were from endocervical glands into which the CIN had grown. Six of normal tissue (N) were analysed, three from epithelium and three from cells lining normal endocervical glands (EG) high-risk type HPV infection eectively represents a dominant`caretaker' mutation.
The`gatekeepers' control cell proliferation and so their disruption is more directly tumorigenic and may arise consequent to a`caretaker' disruption. The data supports the hypothesis that genes at 11q23-25 are mutated early in cervical carcinogenesis. The putative tumour suppressor genes within this region may represent`gatekeepers' enabling the development of invasive sub-clones.
Materials and methods

Cases
One hundred sixty-one consecutive cases of CIN-III diagnosed in 1992 and treated for the condition by diathermy loop excision (DLE) were selected for analysis. Sections 5 mm thick were cut onto slides and lightly stained with haemotoxylin and eosin without acid alcohol treatment. A reference section to aid microdissection was also prepared.
Microdissection
Microdissection was performed as previously described (Bethwaite et al., 1995) . Following xylene dewaxation, tissues were dampened with 70% ethanol and viewed under a dissecting microscope at 640 magni®cation. Discrete units of epithelia were isolated onto the tip of a 22 gauge needle, transferred into 25 ml of digestion buer (200 mM Tris-HCl pH 8.0, 1 mM EDTA, 400 mg/ml proteinase K [Boehringer Mannheim]), overlaid with mineral oil and digested for 3 h at 558C followed by 40 min at 948C. Digested samples were stored at 7708C.
Characterization of sample DNA
To monitor the quality of DNA isolated, 1 ml of tissue digest was electrophoresed through 1.5% agarose (Sigma) and blotted onto nylon ®lter (MSI Magnagraph). Hybridization was for 18 h at 608C with 50 mg/ml nicktranslated digoxigenin-labelled total human DNA in 26SSC (0.3 M sodium chloride, 0.03 M sodium citrate pH 7.0), 0.1% SDS, 1% blocking reagent (Boehringer Mannheim). After washes at 608C in 26SSC, 0.1% SDS the ®lter was incubated with an alkaline phosphatase conjugated antibody to digoxigenin (Boehringer Man- Figure 4 Focal LOH. Case 41 CIN-III tissues from two biopsy sections (Ta and Tb) were analysed. The ®rst was microdissected into nine contiguous units of lesion and three of normal epithelium, and the second into eight of lesion and four of cells lining normal endocervical glands 11q23.3 ± q25 LOH in CIN III MF Evans et al nheim) and the hybridization signal was detected colourimetrically by incubation with nitroblue tetrazolium/5-bromo-4-chloro-3-indoyl phosphate (Hughes et al., 1995) . Extracted DNA sizes ranged from over 1 kb to 300 bp and modal size was 400 bp (data not shown). To assess the DNA yield selections of 1 ml digests were dot blotted and hybridized and detected as before. Quantity was estimated by comparison against a set of control amounts. A yield of approximatley 250 pg per ml digest was typical (data not shown). Figure 5 Loss of alternate alleles. Case 53 was microdissected into 32 contiguous units, eight of normal epithelium and 24 of lesion. Intralesional LOH was identi®ed at three sites. The corresponding H & E section is aligned with microsatellite data 
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PCR analysis of microsatellite sequences
A 10 ml reaction comprised:-1.5 ml tissue digest; 600 nM each primer, (exceptions, D11S29: 400 nM, CD3D: 500 nM); 100 mM dNTPs; 1.5 mM MgCl 2 , (exceptions, D11S901: 3.5 mM, D11S35: 2 mM); 0.05 units of SuperTaq DNA Polymerase (HT Biotechnology); and reaction buer (10 mM Tris-HCl pH 9.0, 50 mM KCl, 0.01% w/v gelatin. 0.1% Triton X-100). Reactions were overlaid with 10 ml of mineral oil and subject to a`hot start' step of 958C for 5 min 858C whilst Taq enzyme was added and 30 cycles of:-denaturation (948C) for 12 s, (exceptions, D11S554, D11S534: 15 s); annealing (D11S554, D11S534 and D11S35: 558C for 15 s; D11S901: 628C for 10 s; D11S897: 578C for 10 s; D11S29: 638C for 10 s; CD3D: 608C for 10 s); and extension (728C) for 10 s (exceptions, D11S554 and D11S534: 20 s). An elongation step of 728C for 5 min completed the PCR. Details of PCR primers are given in Table 1 . Sequences were accessed from the Genome Data Base. One primer from each set was endlabelled with (g32-P) ATP (ICN) using T4 polynucleotide kinase (New England Biolabs). PCRs were performed using a Perkin Elmer 9600 machine. Products were separated in 5% denaturing urea-polyacrylamide-formamide gels (National Diagnostics) 60W for 3 h followed by autoradiography using pre-¯ashed ®lm (Kodak XOMAT AR) with intensifying screens at 7708C for up to 7 days.
Allelic loss assessment
Densitometric analysis of autoradiographs utilized a Roche/NEC image analysis system and densitometric software package (Quantiscan, Biosoft, UK). The ratio of the allelic bands A1 (larger allele) to A2 (smaller) or vice versa for a case when the larger allele was lost were calculated for each microdissected sample. LOH was scored when the allelic ratio from a CIN sample was outside two standard deviations of the normal tissue mean ratio values. This stringent criterion for assessing LOH was adopted given an expected homogeneity of cell type within the epithelium, the relatively degraded character of the sample DNA and the tiny amounts used per PCR (see above).
PCR analysis of HPV sequences
A region of dysplastic epithelium was microdissected and proteinase K digested as before. PCR was performed for an E6/E7 sequence (Fujinaga et al., 1991) . A 50 ml reaction comprised 10 ml of tissue digest, 200 mM dNTPs, 1 mM each primer (5'-3' TGTCAAAAACCGTTGTGTCC and GAGCTGTCGCTTAATTGCTC), 1.25 units SuperTaq, and reaction buer (10 mM Tris-HCl pH 9.0, 50 mM KCl, 1.5 mM MgCl2, 0.01% w/v gelatin. 0.1% Triton X-100). Reactions were overlaid with 25 ml of mineral oil and subject to a hot start followed by 40 cycles consisting of denaturation at 948C for 45 s, annealing at 558C for 1 min and extension at 728C for 1 min with a ®nal elongation step of 728C for 5 min. Products were puri®ed through mini-columns (Qiagen) digested with Eco471 (Ava II) (MBI Fermentas) and subject to electrophoresis through 4% agarose (Sigma). HPV type was identi®able by band size: 157 and 81 bp for HPV 16; 136 and 108 bp for HPV 33. 
